rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2002-3-28
|
pubmed:abstractText |
The chromosome rearrangements inv(16)(p13q22) or t(16;16)(p13;q22) are present in approximately 10% of all cases with de novo acute myeloid leukemia and define a subgroup with a favorable prognosis. Both aberrations result in a CBFB-MYH11 fusion gene that can be detected by RT-PCR.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1466-4860
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
206-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11920247-Chromosome Inversion,
pubmed-meshheading:11920247-Chromosomes, Human, Pair 16,
pubmed-meshheading:11920247-DNA Mutational Analysis,
pubmed-meshheading:11920247-DNA Primers,
pubmed-meshheading:11920247-Humans,
pubmed-meshheading:11920247-Leukemia, Myelomonocytic, Acute,
pubmed-meshheading:11920247-Male,
pubmed-meshheading:11920247-Middle Aged,
pubmed-meshheading:11920247-Oncogene Proteins, Fusion,
pubmed-meshheading:11920247-Prognosis,
pubmed-meshheading:11920247-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:11920247-Translocation, Genetic,
pubmed-meshheading:11920247-Tumor Markers, Biological
|
pubmed:year |
2001
|
pubmed:articleTitle |
Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.
|
pubmed:affiliation |
Institute of Hematology, Erasmus University Rotterdam, The Netherlands. b.vanderreijden@chl.azn.nl
|
pubmed:publicationType |
Journal Article,
Case Reports
|